Abstract:Localization of lipidomes and tracking their spatial changes by mass spectrometry imaging (MSI) is critical for the mechanism studies on living process, disease, and therapeutic treatment. However, due to the strong ion suppression in complex biotissue, the imaging coverage for lipids with low polarity or low abundances, such as glycerolipids and sphingolipids, is usually limited. To address this issue, we utilized a porous graphitic carbon (PGC) material to imprint brain tissue sections for selective enrichment of neutral lipids with polar phospholipids removed. Then, the tissue imprint was scanned for desorption by the ambient liquid extraction MSI system. It was found that on the PGC surface, hydrophobic interaction dominates in protic solvents, and polar interaction dominates in aprotic solvents. Accordingly, methanol was selected as the spray solvent for tissue imprinting, and 75% acetonitrile-methanol was selected as the desorption solvent for the ambient liquid extraction MSI system. The results showed that glycerides had high recoveries after the imprinting-desorption process (recovery ∼ 70%) with phospholipids eliminated (recovery < 7%). To increase the transferring efficiencies of lipids from tissue onto PGC, electrospray was used for solvent application during imprinting, and the signals of diglycerides (DGs) in the imprint MSI of brain tissue increased by 2-3 times as compared to those via air spray. Finally, the new imprint MSI approach was applied to the imaging of the rat cerebellum and was compared with direct tissue MSI. The results showed that with imprint MSI, the coverage of DGs, sphingomyelins (SMs), and ceramides was enhanced by 4-5-fold (32 vs 6, 4 vs 1, and 5 vs 0). The ion images showed that with imprint MSI, higher signal intensities and clearer spatial distribution of DGs and SMs were obtained without interference from phosphatidylcholine signals compared with tissue MSI. This new method provides a complementary approach for traditional MSI to address the issues in imaging poorly ionizable or low-abundance lipids.

Unraveling the drug distribution in brain enabled by MALDI MS imaging with laser-assisted chemical transfer

Development of an Integrated Tissue Pretreatment Protocol for Enhanced MALDI MS Imaging of Drug Distribution in the Brain

Quantitative MALDI Imaging of Spatial Distributions and Dynamic Changes of Tetrandrine in Multiple Organs of Rats

Optimizing neurotransmitter pathway detection by IR-MALDESI-MSI in mouse brain

1,5-Diaminonaphthalene Hydrochloride Assisted Laser Desorption/ionization Mass Spectrometry Imaging of Small Molecules in Tissues Following Focal Cerebral Ischemia.

Enhancement of On-tissue Chemical Derivatization by Laser-Assisted Tissue Transfer for MALDI MS Imaging.

On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI–MS Imaging

Visualizing Neurotransmitters and Metabolites in the Central Nervous System by High Resolution and High Accuracy Mass Spectrometric Imaging

Novel mimetic tissue standards for precise quantitative mass spectrometry imaging of drug and neurotransmitter concentrations in rat brain tissues

Molecular imaging of small molecule drugs in animal tissues using laser desorption postionization mass spectrometry.

MALDI-2 Mass Spectrometry Imaging enables spatial visualization of endocannabinoids in brain

Optimized combination of MALDI MSI and immunofluorescence for neuroimaging of lipids within cellular microenvironments

Three Dimensional Mapping of Neuropeptides and Lipids in Crustacean Brain by Mass Spectral Imaging

4-Nitrocatechol As a Novel Matrix for Low-Molecular-weight Compounds in Situ Detection and Imaging in Biological Tissues by MALDI-MSI

Porous Graphitic Carbon-Based Imprint Mass Spectrometry Imaging with an Ambient Liquid Extraction Technique for Enhancing Coverage of Glycerolipids and Sphingolipids in Brain Tissue

Spatial neurolipidomics—MALDI mass spectrometry imaging of lipids in brain pathologies

2-Hydroxy-5-nitro-3-(trifluoromethyl)pyridine As a Novel Matrix for Enhanced MALDI Imaging of Tissue Metabolites

Expansion Strategy-Driven Micron-Level Resolution Mass Spectrometry Imaging of Lipids in Mouse Brain Tissue

MALDI-MS Imaging of Lipids and Small Molecules in Rat Brain Tissue Based on Graphene Oxide Film Pre-Coated Matrix

Subcellular Chemical Imaging of Structurally Similar Acridine Drugs by Near-Field Laser Desorption/laser Postionization Mass Spectrometry

3-Aminophthalhydrazide (Luminol) as A Novel Matrix for Dual-Polarity MALDI MS Imaging.